Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 4,298 $ 3,926
Restricted cash 63 63
Accounts receivable, net 6,675 4,631
Inventories, net 4,582 4,869
Prepaid expenses and other current assets 4,258 4,074
Total Current Assets 19,876 17,563
Property and equipment, net 205 252
Right-of-use assets, operating lease 305 345
Intangible assets, net 12,732 13,115
Goodwill 18,614 18,614
Other assets 635 1,364
Total Assets 52,367 51,253
Current Liabilities    
Term loans, net 628 7,826
PPP loans 315 190
Other liabilities 41 47
Accounts payable 5,221 3,137
Accrued liabilities 2,090 3,003
Deferred revenue 257 350
Operating lease liability 180 173
Warrant liabilities 46,333 39,850
Total Current Liabilities 55,065 54,576
Non-current Liabilities    
Notes payable, net 19,609 18,910
Term loans, net 5,219 0
Lines of credit, net 4,781 5,023
PPP loans 537 662
Operating lease liability 136 184
Total Non-current Liabilities 30,282 24,779
Total Liabilities 85,347 79,355
Stockholders’ Deficit    
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,004,348 and 51,908,398 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 66 52
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 17,306 and 21,754 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 0 0
Additional paid-in capital 240,847 232,487
Accumulated deficit (273,893) (260,641)
Total Stockholders’ Deficit (32,980) (28,102)
Total Liabilities and Stockholders’ Deficit $ 52,367 $ 51,253
Common stock, authorized (in shares) 200,000,000 200,000,000